168 related articles for article (PubMed ID: 29717769)
21. Integrated profiling identifies SLC5A6 and MFAP2 as novel diagnostic and prognostic biomarkers in gastric cancer patients.
Sun T; Wang D; Ping Y; Sang Y; Dai Y; Wang Y; Liu Z; Duan X; Tao Z; Liu W
Int J Oncol; 2020 Feb; 56(2):460-469. PubMed ID: 31894266
[TBL] [Abstract][Full Text] [Related]
22. Distribution of somatic mutations of cancer-related genes according to microsatellite instability status in Korean gastric cancer.
Park J; Yoo HM; Jang W; Shin S; Kim M; Kim Y; Lee SW; Kim JG
Medicine (Baltimore); 2017 Jun; 96(25):e7224. PubMed ID: 28640116
[TBL] [Abstract][Full Text] [Related]
23. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
[TBL] [Abstract][Full Text] [Related]
24. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
25. The Transcriptomic Landscape of Gastric Cancer: Insights into Epstein-Barr Virus Infected and Microsatellite Unstable Tumors.
Gullo I; Carvalho J; Martins D; Lemos D; Monteiro AR; Ferreira M; Das K; Tan P; Oliveira C; Carneiro F; Oliveira P
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30018250
[TBL] [Abstract][Full Text] [Related]
26. Global gene expression analysis of knockdown Triosephosphate isomerase (TPI) gene in human gastric cancer cell line MGC-803.
Ouyang P; Lin B; Du J; Pan H; Yu H; He R; Huang Z
Gene; 2018 Mar; 647():61-72. PubMed ID: 29307852
[TBL] [Abstract][Full Text] [Related]
27. Cross-platform Data Analysis Reveals a Generic Gene Expression Signature for Microsatellite Instability in Colorectal Cancer.
Pačínková A; Popovici V
Biomed Res Int; 2019; 2019():6763596. PubMed ID: 31008109
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse‑type gastric cancer.
Li S; Yu C; Cheng Y; Du F; Wen G
Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495829
[TBL] [Abstract][Full Text] [Related]
29. Microsatellite Instability Analysis in Gastric Carcinomas of Moroccan Patients.
Nshizirungu JP; Bennis S; Mellouki I; Benajah DA; Lahmidani N; El Bouhaddoutti H; Ibn Majdoub K; Ibrahimi SA; Pires Celeiro S; Viana-Pereira M; Manuel Reis R
Genet Test Mol Biomarkers; 2021 Feb; 25(2):116-123. PubMed ID: 33596142
[No Abstract] [Full Text] [Related]
30. Development and verification of a microsatellite instability-related risk signature for predicting survival and therapy effectiveness in gastric cancer.
Zhang T; Yu S; Zhao S
J Gastrointest Oncol; 2022 Feb; 13(1):84-101. PubMed ID: 35284118
[TBL] [Abstract][Full Text] [Related]
31. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1.
Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES
Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457
[TBL] [Abstract][Full Text] [Related]
32. Pathway- and clinical-factor-based risk model predicts the prognosis of patients with gastric cancer.
Yang J; Bo L; Han T; Ding D; Nie M; Yin K
Mol Med Rep; 2018 May; 17(5):6345-6356. PubMed ID: 29532879
[TBL] [Abstract][Full Text] [Related]
33. Deep learning captures selective features for discrimination of microsatellite instability from pathologic tissue slides of gastric cancer.
Lee SH; Lee Y; Jang HJ
Int J Cancer; 2023 Jan; 152(2):298-307. PubMed ID: 36054320
[TBL] [Abstract][Full Text] [Related]
34.
Yu X; Cao F; Yu Y; Li Y; Zhang J; Xu T; Di Q; Wu G; Zhang Z; Wang R; Li Y
DNA Cell Biol; 2021 Oct; 40(10):1251-1260. PubMed ID: 34491823
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
36. A gastric cancer LncRNAs model for MSI and survival prediction based on support vector machine.
Chen T; Zhang C; Liu Y; Zhao Y; Lin D; Hu Y; Yu J; Li G
BMC Genomics; 2019 Nov; 20(1):846. PubMed ID: 31722674
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
38. Discovery of signature genes in gastric cancer associated with prognosis.
Zhao X; Cai H; Wang X; Ma L
Neoplasma; 2016; 63(2):239-45. PubMed ID: 26774142
[TBL] [Abstract][Full Text] [Related]
39. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
40. A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer.
Cai Z; Song H; Fingerhut A; Sun J; Ma J; Zhang L; Li S; Yu C; Zheng M; Zang L
BMC Cancer; 2021 Mar; 21(1):319. PubMed ID: 33765970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
